Literature DB >> 9649552

The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

M Mall1, M Bleich, R Greger, R Schreiber, K Kunzelmann.   

Abstract

Cystic fibrosis (CF) airway cells, besides their well-known defect in cAMP-dependent Cl- conductance, are characterized by an enhanced Na+ conductance. In this study we have examined the Na+ conductance in human respiratory tract by measuring transepithelial voltage and resistance (Vte, Rte) and by assessing membrane voltages (Vm) of freshly isolated airway epithelial cells from CF and non-CF patients. Basal amiloride inhibitable (10 micromol/liter) equivalent short circuit current (Isc = Vte/Rte) was significantly increased in CF compared with non-CF tissues. After stimulation by forskolin (10 micromol/liter) a significant depolarization of Vm corresponding to the cAMP-dependent activation of a Cl- conductance was observed in non-CF but not in CF airway cells. In non-CF tissue but not in CF tissue the effects of amiloride and N-methyl-D-glucamine on Vm were attenuated in the presence of forskolin. Also the amiloride-inhibitable Isc was significantly reduced by forskolin (1 micromol/liter) and isobutylmethylxanthine (IBMX; 100 micromol/liter) only in non-CF tissue. We conclude that cystic fibrosis transmembrane conductance regulator acts as a downregulator of epithelial Na+ channels in human airways. This downregulation of epithelial Na+ channels is absent in CF airways, leading to hyperabsorption and to the characteristic increase in mucus viscosity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649552      PMCID: PMC509060          DOI: 10.1172/JCI2729

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Chloride secretion and function of serous and mucous cells of human airway glands.

Authors:  W E Finkbeiner; B Q Shen; J H Widdicombe
Journal:  Am J Physiol       Date:  1994-08

2.  The amiloride inhibitable Na+ conductance of rat colonic crypt cells is suppressed by forskolin.

Authors:  D Ecke; M Bleich; R Greger
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

3.  KVLQT channels are inhibited by the K+ channel blocker 293B.

Authors:  M Bleich; M Briel; A E Busch; H J Lang; U Gerlach; H Gögelein; R Greger; K Kunzelmann
Journal:  Pflugers Arch       Date:  1997-08       Impact factor: 3.657

Review 4.  Regulation of epithelial ion channels by the cystic fibrosis transmembrane conductance regulator.

Authors:  R Greger; M Mall; M Bleich; D Ecke; R Warth; N Riedemann; K Kunzelmann
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

5.  Na+ and Cl- conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis.

Authors:  K Kunzelmann; S Kathöfer; R Greger
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

6.  Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator.

Authors:  K Kunzelmann; G L Kiser; R Schreiber; J R Riordan
Journal:  FEBS Lett       Date:  1997-01-06       Impact factor: 4.124

7.  Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes.

Authors:  M Mall; A Hipper; R Greger; K Kunzelmann
Journal:  FEBS Lett       Date:  1996-02-26       Impact factor: 4.124

8.  Culture-dependent expression of Na+ conductances in airway epithelial cells.

Authors:  K Kunzelmann; S Kathöfer; A Hipper; D C Gruenert; R Gregner
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

9.  Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.

Authors:  R C Boucher; M J Stutts; M R Knowles; L Cantley; J T Gatzy
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

10.  Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator.

Authors:  I I Ismailov; M S Awayda; B Jovov; B K Berdiev; C M Fuller; J R Dedman; M Kaetzel; D J Benos
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

View more
  69 in total

1.  The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.

Authors:  R Schreiber; A Hopf; M Mall; R Greger; K Kunzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors.

Authors:  Ossama B Kashlan; Thomas R Kleyman
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

3.  Luminal cholinergic signalling in airway lining fluid: a novel mechanism for activating chloride secretion via Ca²⁺-dependent Cl⁻ and K⁺ channels.

Authors:  Monika I Hollenhorst; Katrin S Lips; Miriam Wolff; Jürgen Wess; Stefanie Gerbig; Zoltan Takats; Wolfgang Kummer; Martin Fronius
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 4.  CFTR and TNR-CFTR expression and function in the kidney.

Authors:  Jackson Souza-Menezes; Geórgia da Silva Feltran; Marcelo M Morales
Journal:  Biophys Rev       Date:  2014-05-07

Review 5.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

6.  CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.

Authors:  G Nagel; P Barbry; H Chabot; E Brochiero; K Hartung; R Grygorczyk
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

Review 7.  Ion Channel Modulators in Cystic Fibrosis.

Authors:  Martina Gentzsch; Marcus A Mall
Journal:  Chest       Date:  2018-05-08       Impact factor: 9.410

8.  The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration.

Authors:  J König; R Schreiber; T Voelcker; M Mall; K Kunzelmann
Journal:  EMBO Rep       Date:  2001-10-17       Impact factor: 8.807

9.  Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.

Authors:  N N Sanders; H Franckx; K De Boeck; J Haustraete; S C De Smedt; J Demeester
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

10.  Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula.

Authors:  K J Demmers; D Carter; S Fan; P Mao; N J Maqbool; B J McLeod; R Bartolo; A G Butt
Journal:  J Comp Physiol B       Date:  2009-12-12       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.